Cetuximab rechallenge in RAS, BRAF, EGFR-ECD wild type metastatic colorectal cancer (mCRC) patients treated with anti-EGFR therapies in first line: The CITRIC study

Por: Vivas, CS, Salva, F, Fernandez-Rodriguez, C, Orduna, VA, Losa, F, Paez, D, Vidal, J, Salud, A, Fernandez, PR, Aguilera, MS, Tarazona, N, Hernandez-Yague, X, Romero, LL, Garcia-Carbonero, R, Rivera, F, Gallego, RA, Bellosillo, B and Montagut, C

---

Publicada: 1 jun 2022

---

---

Filiaciones:
Vivas, CS:
 Hosp Duran & Reynals, Catalan Inst Oncol, Barcelona, Spain

Salva, F:
 Vall dHebron Inst Oncol, Barcelona, Spain

Fernandez-Rodriguez, C:
 Hosp Mar, Mol Biol Lab, Pathol Dpt, Barcelona, Spain

Orduna, VA:
 Hosp Miguel Servet, Zaragoza, Spain

Losa, F:
 Lhosp Barcelona, Catalan Inst Oncol, Barcelona, Spain

Paez, D:
 Hosp Santa Creu & Sant Pau, Barcelona, Spain

Vidal, J:
 Inst Salud Carlos III, CIBERONC, Hosp Mar IMIM, Med Oncol Dept, Barcelona, Spain

Salud, A:
 Hosp Lleida Arnau Vilanova, Lerida, Spain

Fernandez, PR:
 Parc Tauli Hosp Univ, Sabadell, Spain

Aguilera, MS:
 Univ Valencia, Gen Univ Hosp, Dept Med Oncol, Ciberonc, Valencia, Spain

Tarazona, N:
 Univ Valencia, INCLIVA Biomed Res Inst, Valencia, Spain

 Inst Salud Carlos III, CIBERONC, Valencia, Spain

Hernandez-Yague, X:
 Hosp Josep Trueta, Catalan Inst Oncol, Girona, Spain

:
 Germans Trias & Pujol Univ Hosp, Catalan Inst Oncol Badalona, Med Oncol Dept, Badalona Applied Res Grp Oncol, Badalona, Spain

Garcia-Carbonero, R:
 Univ Complutense Madrid, Ctr Nacl Invest Oncol, Imas12, Hosp Univ Octubre 12, Madrid, Spain

Rivera, F:
 Univ Hosp Marques Valdecilla, IDIVAL, Santander, Spain

Gallego, RA:
 Hosp Madrid Norte Sanchinarro, Madrid, Spain

Bellosillo, B:
 Hosp Mar, Mol Biol Lab, Pathol Dpt, Barcelona, Spain

Montagut, C:
 Inst Salud Carlos III, CIBERONC, Hosp Mar IMIM, Med Oncol Dept, Barcelona, Spain